Did not become law. It stopped in the General Assembly on February 15, 2017. The 2016–2017 session has ended.
2016–2017 Session
Assembly Bill 4338
"Prescription Drug Consumer Transparency Act;" requires pharmacy benefits managers to disclose certain information to benefit plan purchasers and to establish toll-free telephone number for certain inquiries.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the General Assembly
Sponsor from Nov 14
Chief co-sponsor from Feb 13, 2017
Chief co-sponsor from Mar 16, 2017
Chief co-sponsor from May 18, 2017
Pamela R. Lampitt, Raj Mukherji, Eric Houghtaling
Chief co-sponsors from Dec 7, 2017
Its course
November 21, 2016 to February 15, 2017, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action3 actions on 3 days
In the General AssemblyNov 21 to Feb 15 · stopped86 days
Financial Institutions and InsuranceNov 21 to Jan 3070 days
Amendments
Each amendment offered, and what became of it.
General Assembly committee amendmentAdopted
Adopted Jan 30, 2017
General Assembly floor amendmentAdopted
Adopted Feb 15, 2017
Text
Each version as the Legislature printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the Legislature published it is below.
In the General Assembly Nov 21 – Feb 15, 2017
- Nov 21Introduced in the General Assembly and sent to Financial Institutions and Insurance
- Jan 30, 2017Financial Institutions and Insurance recommended it as amended
- Read a second time
- Feb 15, 2017Amended on the floor and read a second time